Subscribe to our newsletter
Latest Insights & Developments
Bringing you the latest updates, stories, and developments showcasingour journey towards innovation. From pioneering AI-driven solutionsthat enhance procurement analytics to leveraging vast datasets forinsightful decision-making, Vamstar stands at the forefront ofindustry change.
Join us as we explore the impact of our technological advancementsand innovative strategies, driving efficiency, reducing costs, andopening new opportunities for organisations worldwide.
Stay informed with our curated news and insights, and see firsthandhow Vamstar is setting new standards in Life Science and Healthcare.
Navigating MedTech
Industry in 2024
This Report, is a comprehensive analysis that sheds light on the current state and future opportunities of the MedTech Industry.
This year’s report is particularly significant as it navigates through the aftermath of COVID-19, inflationary pressures, and geopolitical uncertainties.
Our findings reveal that the MedTech industry is pivoting from these challenges with resilience and agility.
Register to Explore
Supply side outcomes
Register to Explore
Buy side outcomes
Industry Reports
Using AI for Biosimilars Market Intelligence
Please provide your email to download the resource
Articles
Newest
- Newest
- Featured
- Most Popular
- Latest
-
Enhanced EU Regulations for In Vitro Diagnostic Devices: A Comprehensive Overview
EU updates IVDR, extending compliance deadlines and accelerating EUDAMED rollout.10 min read -
Japan’s Ascendancy in Digital Health: A Model for Global Innovation
Japan has emerged as a leader in the digital health sector, with its market projected to reach $6.15 billion by the end of the year, far surpassing China’s $54 million. This significant growth is underpinned by Japan's rich history of technological innovation, now cleverly extended into the healthcare domain. For instance, Takeda's "Care for One" program exemplifies how digital technologies can revolutionise monitoring and treatment strategies for chronic diseases such as Parkinson’s. This app-based solution, utilising the capabilities of the Apple Watch, enables continuous monitoring of symptoms, providing precise data to tailor more effective treatment plans. The rapid adoption of such innovative healthcare solutions is also driven by Japan's demographic realities—an aging population that necessitates scalable and efficient healthcare technologies. Digital tools like Iris's AI-powered nodoca device, which can diagnose influenza quickly and non-invasively, demonstrate how technology is being adapted to meet the needs of Japan's elderly population. Furthermore, Japan’s proactive digital health policies have facilitated a fertile environment for growth and innovation. The government's initiatives, such as regulatory support for digital therapeutics and incentives for their adoption, underscore a commitment to integrating these technologies into the national healthcare system. This approach not only enhances patient care but also positions Japan as a global leader in digital health, offering valuable lessons for other countries looking to harness the potential of technology in healthcare.6 min read -
Latest Developments in the Pharmaceutical Industry: Innovations and Advances in 2024
The pharmaceutical industry is experiencing a period of rapid innovation and development, fuelled by technological advances, regulatory changes, and a heightened focus on patient-centric care. This article explores the most recent and significant developments that are shaping the future of healthcare and pharmaceuticals in 2024.5 min read -
Automating Pricing Decisions Through AI-powered Datasets
In the rapidly evolving pharmaceutical sector, where cost pressures from market dynamics sharply erode profits, traditional drug pricing strategies fall short. These methods often overlook essential data, curbing profitability and increasing the risk of costly pricing errors. Vamstar's Polaris platform addresses these issues head-on by integrating Artificial Intelligence (AI) with a meticulously curated dataset, which automates and refines the pricing process. This advanced platform not only collects and analyses vast amounts of relevant data but also applies sophisticated pattern recognition and predictive analytics to ensure optimal pricing decisions in challenging markets. By moving away from outdated manual processes plagued by errors (like those seen with Excel), oversimplified models, and ineffective revenue management systems, Polaris equips suppliers with the tools to implement dynamic, precise pricing strategies that enhance profitability and mitigate risk. Dive into the future of Pharma pricing with Vamstar’s Polaris—where innovation meets precision.6 min read -
Latest Recommendations for Medicine Procurement
In the rapidly evolving pharmaceutical sector, where cost pressures from market dynamics sharply erode profits, traditional drug pricing strategies fall short. These methods often overlook essential data, curbing profitability and increasing the risk of costly pricing errors. Vamstar's Polaris platform addresses these issues head-on by integrating Artificial Intelligence (AI) with a meticulously curated dataset, which automates and refines the pricing process. This advanced platform not only collects and analyses vast amounts of relevant data but also applies sophisticated pattern recognition and predictive analytics to ensure optimal pricing decisions in challenging markets. By moving away from outdated manual processes plagued by errors (like those seen with Excel), oversimplified models, and ineffective revenue management systems, Polaris equips suppliers with the tools to implement dynamic, precise pricing strategies that enhance profitability and mitigate risk. Dive into the future of Pharma pricing with Vamstar’s Polaris—where innovation meets precision.10 min read
Vamstar Surveys
Innovating for Impact
Book a 30 minutes meeting with us
Welcome to our scheduling page! Please choose an available date below to get started.
30 minutes meeting
We'll email you the meeting link